166 related articles for article (PubMed ID: 1964216)
1. [The possible sources of hyperandrogenism in hirsutism in girls].
Semicheva TV; Kolesnikova GS; Pishchulin AA; Pankova SS; Dobracheva AD; Martysh NS
Probl Endokrinol (Mosk); 1990; 36(5):53-5. PubMed ID: 1964216
[TBL] [Abstract][Full Text] [Related]
2. [The differential diagnosis of hairy virilism in polycystic ovaries from adrenal cortical hirsutism].
Maleeva A; Milkov V; Visheva N; Kekhaĭova M
Vutr Boles; 1990; 29(3):93-9. PubMed ID: 2178292
[TBL] [Abstract][Full Text] [Related]
3. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
Bardin CW; Hembree WC; Lipsett MB
J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
[No Abstract] [Full Text] [Related]
4. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
5. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
[TBL] [Abstract][Full Text] [Related]
6. Hyperandrogenism. Tests that simplify evaluation.
Hammond MG; Talbert LM; Groff TR
Postgrad Med; 1986 Feb; 79(3):107-13. PubMed ID: 3003722
[No Abstract] [Full Text] [Related]
7. [Hormonal aspects in the diagnosis of hirsutism].
Maleev A; Milkov V
Akush Ginekol (Sofiia); 1989; 28(1):60-6. PubMed ID: 2742087
[TBL] [Abstract][Full Text] [Related]
8. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism.
Lisse K; Schürenkämper P; Friedrich W; Rutkowsky J
Acta Endocrinol (Copenh); 1980 Feb; 93(2):216-22. PubMed ID: 7189630
[TBL] [Abstract][Full Text] [Related]
9. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
[TBL] [Abstract][Full Text] [Related]
10. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981
[TBL] [Abstract][Full Text] [Related]
12. [ACTH-dependency of hirsutism; significance and critical aspects of function tests].
Radian N; Ciocîrdia C; Tache A; Cristoveanu A; Bunea M; Panatiu G; Marinescu I
Endocrinologie; 1978; 16(2):116-27. PubMed ID: 209528
[No Abstract] [Full Text] [Related]
13. [Hirsutism and androgenic menstrual cycle irregularities].
Carol W; Wilke I
Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):153-7. PubMed ID: 2058208
[No Abstract] [Full Text] [Related]
14. [Critical study of the characterization of hyperandrogenism in a group of obese women].
Cordray JP; Merceron RE; Nys P; Guillerd X; Reboul P; Rainaut M
Rev Fr Gynecol Obstet; 1995 Oct; 90(10):403-8. PubMed ID: 8539505
[TBL] [Abstract][Full Text] [Related]
15. Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women.
Coskun A; Ercan O; Arikan DC; Özer A; Kilinc M; Kiran G; Kostu B
Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):167-71. PubMed ID: 21041013
[TBL] [Abstract][Full Text] [Related]
16. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
17. [Androgens in the plasma of women with hirsutism (author's transl)].
Demisch K; Magnet W; Neubauer M; Schöffling K
Dtsch Med Wochenschr; 1975 May; 100(20):1117-23. PubMed ID: 123849
[TBL] [Abstract][Full Text] [Related]
18. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
Thompson DL; Horton N; Rittmaster RS
Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
[TBL] [Abstract][Full Text] [Related]
19. 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism.
Hudson RW; Lochnan HA; Danby FW; Margesson LJ; Strang BK; Kimmett SM
Fertil Steril; 1990 Dec; 54(6):1065-71. PubMed ID: 2174005
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
Chanukvadze D; Kristesashvili J
Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
